Medtronic trains surgeons with iPads; Medicare-related diagnostic imaging declines;

 @FierceMedDev: Zoll grabs Minnesota startup with FDA challenges. News | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: a look at a colon cancer test that could detect tumor cells before they take root. DxExtra | Follow @MarkHFierce

 @DamianFierce: Our latest industry voices piece: A Dx insider weighs in on the implications of SCOTUS' MYGN ruling. More | Follow @DamianFierce

 @MichaelGFierce: 'Bioadhesive' coating helps oral drugs deliver payload. Item | Follow @MichaelGFierce

> Medtronic ($MDT) uses iPad simulations and games to train surgical clients how to use some surgical tools. Story

> Israel's MitrAssist has raised $1 million from angel investors and a private, strategic investor toward development of an implant to treat mitral regurgitation. Story

> Atossa Genetics, a developer of breast health devices, hired its first medical director. Item

> Transcranial magnetic stimulation, or TMS, is showing promise as a treatment for depression, but insurers haven't widely covered it yet. Blog

> Physicians are steadily reducing their use of diagnostic imaging with Medicare patients, a study conducted by the Harvey L. Neiman Health Policy Institute has concluded. Item

> ConvaTec, a maker of devices and equipment in areas including ostomy care, wound therapy and infusion, has named its global finance head as acting CFO. Item

Biotech News

 @FierceBiotech: UPDATED: A long lineup of potential buyers crowds Onyx picture. Article | Follow @FierceBiotech

 @JohnCFierce: MannKind shoulders $160M in debt for PhIII inhaled-insulin gamble. Story | Follow @JohnCFierce

 @RyanMFierce: Celgene, others regenerate biotech Tengion's finances with $33.6M. Report | Follow @RyanMFierce

> Achillion shares skid lower after FDA puts a hold on hep C drug. More

> What's the most valuable drug in the global pipeline? Report

Pharma News

 @FiercePharma: Will the new weight loss drugs ever prosper? The NYT ticks off the odds stacked against them: Article | Follow @FiercePharma

> Expect a long slog for diet drugs Qsymia, Belviq. Story

> Who's hiring in Big Pharma? Novartis, Roche, Sanofi top the list. More

> Is GlaxoSmithKline's China probe a harbinger of more? Report

Pharma Manufacturing News

 @CarlyHFierce: 160 of India's manufacturing facilities prepared for new EU regulations going into effect today. Item | Follow @CarlyHFierce

>  With Aspen deal, Merck finally able to shrink legacy Organon sites. Story

> Med Prep slapped with consent decree as FDA eyes compounders. More

> Glass particles once again trigger Fresenius Kabi recall. Article

> King Pharma settles for $2.2M after violating pharma emissions standards. Story

Biotech Research News

 @EmilyMFierce: Mouse models predict chemo treatment response in humans. Report | Follow @EmilyMFierce

> Texas A&M launches multimillion-dollar genomics research project. More

> Report: U.K. health body stifling stem cell research. News

> Nonprofit licenses MS mouse model to Biogen Idec to develop new therapies. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.